{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:55:36Z","timestamp":1791244536181,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273100"],"award-info":[{"award-number":["82273100"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02677-8","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:05:15Z","timestamp":1777644315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A non-complement role for C1R rewires integrin and death-receptor signaling to drive renal cancer metastasis"],"prefix":"10.1186","volume":"25","author":[{"given":"Haotian","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaochen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runze","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglian","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tailong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhe","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyi","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"2677_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","volume":"75","author":"U Capitanio","year":"2019","unstructured":"Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, Gore JL, Sun M, Wood C, Russo P. Epidemiology of Renal Cell Carcinoma. Eur Urol. 2019;75:74\u201384.","journal-title":"Eur Urol"},{"key":"2677_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2677_CR3","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2677_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eururo.2014.04.029","volume":"67","author":"B Shuch","year":"2015","unstructured":"Shuch B, Amin A, Armstrong AJ, Eble JN, Ficarra V, Lopez-Beltran A, Martignoni G, Rini BI, Kutikov A. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol. 2015;67:85\u201397.","journal-title":"Eur Urol"},{"key":"2677_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","volume":"35","author":"T Powles","year":"2024","unstructured":"Powles T, Albiges L, Bex A, Comperat E, Gr\u00fcnwald V, Kanesvaran R, Kitamura H, McKay R, Porta C, Procopio G, et al. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2024;35:692\u2013706.","journal-title":"Ann Oncol"},{"key":"2677_CR6","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1038\/s41388-020-1234-3","volume":"39","author":"MM Wolf","year":"2020","unstructured":"Wolf MM, Kimryn Rathmell W, Beckermann KE. Modeling clear cell renal cell carcinoma and therapeutic implications. Oncogene. 2020;39:3413\u201326.","journal-title":"Oncogene"},{"key":"2677_CR7","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1200\/JCO.2005.04.8280","volume":"24","author":"SE Eggener","year":"2006","unstructured":"Eggener SE, Yossepowitch O, Pettus JA, Snyder ME, Motzer RJ, Russo P. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol. 2006;24:3101\u20136.","journal-title":"J Clin Oncol"},{"key":"2677_CR8","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.7150\/ijbs.68980","volume":"18","author":"W Liu","year":"2022","unstructured":"Liu W, Yan B, Yu H, Ren J, Peng M, Zhu L, Wang Y, Jin X, Yi L. OTUD1 stabilizes PTEN to inhibit the PI3K\/AKT and TNF-alpha\/NF-kappaB signaling pathways and sensitize ccRCC to TKIs. Int J Biol Sci. 2022;18:1401\u201314.","journal-title":"Int J Biol Sci"},{"key":"2677_CR9","doi-asserted-by":"crossref","unstructured":"Sherman RL, Firth AU, Henley SJ, Siegel RL, Negoita S, Sung H, Kohler BA, Anderson RN, Cucinelli J, Scott S et al. Annual Report to the Nation on the Status of Cancer, featuring state-level statistics after the onset of the COVID-19 pandemic. Cancer. 2025;131:e35833.","DOI":"10.1002\/cncr.35833"},{"key":"2677_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ctrv.2018.07.009","volume":"70","author":"MB Atkins","year":"2018","unstructured":"Atkins MB, Tannir NM. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma. Cancer Treat Rev. 2018;70:127\u201337.","journal-title":"Cancer Treat Rev"},{"key":"2677_CR11","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1186\/s12889-023-15647-2","volume":"23","author":"X Zhan","year":"2023","unstructured":"Zhan X, Chen T, Liu Y, Wan H, Liu X, Deng X, Fu B, Xiong J. Trends in cause of death among patients with renal cell carcinoma in the United States: a SEER-based study. BMC Public Health. 2023;23:770.","journal-title":"BMC Public Health"},{"key":"2677_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging Biological Principles of Metastasis. Cell. 2017;168:670\u201391.","journal-title":"Cell"},{"key":"2677_CR13","doi-asserted-by":"publisher","first-page":"111298","DOI":"10.1016\/j.celrep.2022.111298","volume":"40","author":"T Pereira-Veiga","year":"2022","unstructured":"Pereira-Veiga T, Schneegans S, Pantel K, Wikman H. Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance. Cell Rep. 2022;40:111298.","journal-title":"Cell Rep"},{"key":"2677_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/carcin\/bgac014","volume":"43","author":"X Chen","year":"2022","unstructured":"Chen X, Zhang X, Jiang Y, Zhang X, Liu M, Wang S, Liu S, Liang H, Liu C. YAP1 activation promotes epithelial-mesenchymal transition and cell survival of renal cell carcinoma cells under shear stress. Carcinogenesis. 2022;43:301\u201310.","journal-title":"Carcinogenesis"},{"key":"2677_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ng0594-85","volume":"7","author":"JR Gnarra","year":"1994","unstructured":"Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet. 1994;7:85\u201390.","journal-title":"Nat Genet"},{"key":"2677_CR16","doi-asserted-by":"crossref","unstructured":"Wang J, Luo Z, Lin L, Sui X, Yu L, Xu C, Zhang R, Zhao Z, Zhu Q, An B et al. Anoikis-Associated Lung Cancer Metastasis: Mechanisms and Therapies. Cancers (Basel). 2022;14:4791.","DOI":"10.3390\/cancers14194791"},{"key":"2677_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrm1789","volume":"7","author":"KR Legate","year":"2006","unstructured":"Legate KR, Monta\u00f1ez E, Kudlacek O, F\u00e4ssler R. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol. 2006;7:20\u201331.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2677_CR18","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1158\/0008-5472.CAN-17-3024","volume":"78","author":"M Rahmani","year":"2018","unstructured":"Rahmani M, Nkwocha J, Hawkins E, Pei X, Parker RE, Kmieciak M, Leverson JD, Sampath D, Ferreira-Gonzalez A, Grant S. Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells. Cancer Res. 2018;78:3075\u201386.","journal-title":"Cancer Res"},{"key":"2677_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/A:1015312119693","volume":"7","author":"J Grossmann","year":"2002","unstructured":"Grossmann J. Molecular mechanisms of detachment-induced apoptosis\u2013Anoikis. Apoptosis. 2002;7:247\u201360.","journal-title":"Apoptosis"},{"key":"2677_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.canlet.2008.05.029","volume":"272","author":"CD Simpson","year":"2008","unstructured":"Simpson CD, Anyiwe K, Schimmer AD. Anoikis resistance and tumor metastasis. Cancer Lett. 2008;272:177\u201385.","journal-title":"Cancer Lett"},{"key":"2677_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cyto.2015.02.007","volume":"74","author":"MI Vazquez","year":"2015","unstructured":"Vazquez MI, Catalan-Dibene J, Zlotnik A. B cells responses and cytokine production are regulated by their immune microenvironment. Cytokine. 2015;74:318\u201326.","journal-title":"Cytokine"},{"key":"2677_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/imr.12644","volume":"283","author":"ME Raeber","year":"2018","unstructured":"Raeber ME, Zurbuchen Y, Impellizzieri D, Boyman O. The role of cytokines in T-cell memory in health and disease. Immunol Rev. 2018;283:176\u201393.","journal-title":"Immunol Rev"},{"key":"2677_CR23","doi-asserted-by":"publisher","first-page":"104254","DOI":"10.1016\/j.cellimm.2020.104254","volume":"359","author":"R Weber","year":"2021","unstructured":"Weber R, Groth C, Lasser S, Arkhypov I, Petrova V, Altevogt P, Utikal J, Umansky V. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Cell Immunol. 2021;359:104254.","journal-title":"Cell Immunol"},{"key":"2677_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/19336918.2017.1307482","volume":"12","author":"Y Chen","year":"2018","unstructured":"Chen Y, Liu J, Lv P, Gao J, Wang M, Wang Y. IL-6 is involved in malignancy and doxorubicin sensitivity of renal carcinoma cells. Cell Adh Migr. 2018;12:28\u201336.","journal-title":"Cell Adh Migr"},{"key":"2677_CR25","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1128\/MCB.01164-08","volume":"29","author":"MA Smit","year":"2009","unstructured":"Smit MA, Geiger TR, Song JY, Gitelman I, Peeper DS. A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol. 2009;29:3722\u201337.","journal-title":"Mol Cell Biol"},{"key":"2677_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.31083\/j.fbl2904138","volume":"29","author":"M Tang","year":"2024","unstructured":"Tang M, Zhao S, Ren L, Li Q, Li L, Wang C, Meng C, Chen Y, Hu W. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression. Front Biosci (Landmark Ed). 2024;29:138.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2677_CR27","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jid.2021.10.008","volume":"142","author":"K Viiklepp","year":"2022","unstructured":"Viiklepp K, Nissinen L, Ojalill M, Riihil\u00e4 P, Kallajoki M, Meri S, Heino J, K\u00e4h\u00e4ri VM. C1r Upregulates Production of Matrix Metalloproteinase-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 2022;142:1478\u2013e14881479.","journal-title":"J Invest Dermatol"},{"key":"2677_CR28","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.ccell.2022.11.001","volume":"40","author":"R Li","year":"2022","unstructured":"Li R, Ferdinand JR, Loudon KW, Bowyer GS, Laidlaw S, Muyas F, Mamanova L, Neves JB, Bolt L, Fasouli ES, et al. Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer. Cancer Cell. 2022;40:1583\u2013e15991510.","journal-title":"Cancer Cell"},{"key":"2677_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.ccell.2021.02.015","volume":"39","author":"K Bi","year":"2021","unstructured":"Bi K, He MX, Bakouny Z, Kanodia A, Napolitano S, Wu J, Grimaldi G, Braun DA, Cuoco MS, Mayorga A, et al. Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma. Cancer Cell. 2021;39:649\u2013e661645.","journal-title":"Cancer Cell"},{"key":"2677_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41698-023-00441-5","volume":"7","author":"AM Raghubar","year":"2023","unstructured":"Raghubar AM, Matigian NA, Crawford J, Francis L, Ellis R, Healy HG, Kassianos AJ, Ng MSY, Roberts MJ, Wood S, Mallett AJ. High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints. NPJ Precis Oncol. 2023;7:88.","journal-title":"NPJ Precis Oncol"},{"key":"2677_CR31","doi-asserted-by":"publisher","first-page":"4796","DOI":"10.1158\/0008-5472.CAN-14-0210","volume":"74","author":"CA von Roemeling","year":"2014","unstructured":"von Roemeling CA, Radisky DC, Marlow LA, Cooper SJ, Grebe SK, Anastasiadis PZ, Tun HW, Copland JA. Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4. Cancer Res. 2014;74:4796\u2013810.","journal-title":"Cancer Res"},{"key":"2677_CR32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1158\/1541-7786.MCR-17-0636","volume":"17","author":"HY Nam","year":"2019","unstructured":"Nam HY, Chandrashekar DS, Kundu A, Shelar S, Kho EY, Sonpavde G, Naik G, Ghatalia P, Livi CB, Varambally S, Sudarshan S. Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis. Mol Cancer Res. 2019;17:84\u201396.","journal-title":"Mol Cancer Res"},{"key":"2677_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","volume":"33","author":"R Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33:495\u2013502.","journal-title":"Nat Biotechnol"},{"key":"2677_CR34","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"2677_CR35","doi-asserted-by":"publisher","first-page":"217259","DOI":"10.1016\/j.canlet.2024.217259","volume":"604","author":"C Zhang","year":"2024","unstructured":"Zhang C, Gou X, Lai G, Li K, Zhu X, Liu N, Kuang Y, Ren K, Xie Y, Xu Y, et al. Single-nucleus sequencing unveils heterogeneity in renal cell carcinomas microenvironment: Insights into pathogenic origins and treatment-responsive cellular subgroups. Cancer Lett. 2024;604:217259.","journal-title":"Cancer Lett"},{"key":"2677_CR36","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang L, Yu X, Zheng L, Zhang Y, Li Y, Fang Q, Gao R, Kang B, Zhang Q, Huang JY, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. 2018;564:268\u201372.","journal-title":"Nature"},{"key":"2677_CR37","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141.","journal-title":"Innov (Camb)"},{"key":"2677_CR38","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister C, Satija R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019;20:296.","journal-title":"Genome Biol"},{"key":"2677_CR39","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W. Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"2677_CR40","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1038\/s41467-022-30638-4","volume":"13","author":"YI Chen","year":"2022","unstructured":"Chen YI, Chang CC, Hsu MF, Jeng YM, Tien YW, Chang MC, Chang YT, Hu CM, Lee WH. Homophilic ATP1A1 binding induces activin A secretion to promote EMT of tumor cells and myofibroblast activation. Nat Commun. 2022;13:2945.","journal-title":"Nat Commun"},{"key":"2677_CR41","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/ncb3250","volume":"17","author":"J Alanko","year":"2015","unstructured":"Alanko J, Mai A, Jacquemet G, Schauer K, Kaukonen R, Saari M, Goud B, Ivaska J. Integrin endosomal signalling suppresses anoikis. Nat Cell Biol. 2015;17:1412\u201321.","journal-title":"Nat Cell Biol"},{"key":"2677_CR42","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.2174\/0929867043363703","volume":"11","author":"F Mollinedo","year":"2004","unstructured":"Mollinedo F, Gajate C, Mart\u00edn-Santamar\u00eda S, Gago F. ET-18-OCH3 (edelfosine): a selective antitumour lipid targeting apoptosis through intracellular activation of Fas\/CD95 death receptor. Curr Med Chem. 2004;11:3163\u201384.","journal-title":"Curr Med Chem"},{"key":"2677_CR43","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2677_CR44","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"2677_CR45","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, \u017d\u00eddek A, Potapenko A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583\u20139.","journal-title":"Nature"},{"key":"2677_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-0716-3441-7_5","volume":"2714","author":"A Singh","year":"2024","unstructured":"Singh A, Copeland MM, Kundrotas PJ, Vakser IA. GRAMM Web Server for Protein Docking. Methods Mol Biol. 2024;2714:101\u201312.","journal-title":"Methods Mol Biol"},{"key":"2677_CR47","doi-asserted-by":"publisher","first-page":"e883","DOI":"10.1002\/ctm2.883","volume":"12","author":"A Reustle","year":"2022","unstructured":"Reustle A, Menig LS, Leuthold P, Hofmann U, St\u00fchler V, Schmees C, Becker M, Haag M, Klumpp V, Winter S, et al. Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma. Clin Transl Med. 2022;12:e883.","journal-title":"Clin Transl Med"},{"key":"2677_CR48","doi-asserted-by":"publisher","first-page":"e2938","DOI":"10.1002\/iub.2938","volume":"77","author":"H Ren","year":"2025","unstructured":"Ren H, Chen X, Ji M, Song W, Cao L, Guo X. CRYAB is upregulated and predicts clinical prognosis in kidney renal clear cell carcinoma. IUBMB Life. 2025;77:e2938.","journal-title":"IUBMB Life"},{"key":"2677_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","volume":"17","author":"E Jonasch","year":"2021","unstructured":"Jonasch E, Walker CL, Rathmell WK. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol. 2021;17:245\u201361.","journal-title":"Nat Rev Nephrol"},{"key":"2677_CR50","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/cbin.11896","volume":"46","author":"M Raeisi","year":"2022","unstructured":"Raeisi M, Zehtabi M, Velaei K, Fayyazpour P, Aghaei N, Mehdizadeh A. Anoikis in cancer: The role of lipid signaling. Cell Biol Int. 2022;46:1717\u201328.","journal-title":"Cell Biol Int"},{"key":"2677_CR51","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","volume":"1833","author":"P Paoli","year":"2013","unstructured":"Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013;1833:3481\u201398.","journal-title":"Biochim Biophys Acta"},{"key":"2677_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12964-023-01338-3","volume":"22","author":"C Su","year":"2024","unstructured":"Su C, Mo J, Dong S, Liao Z, Zhang B, Zhu P. Integrin\u03b2-1 in disorders and cancers: molecular mechanisms and therapeutic targets. Cell Commun Signal. 2024;22:71.","journal-title":"Cell Commun Signal"},{"key":"2677_CR53","doi-asserted-by":"publisher","first-page":"11894","DOI":"10.1073\/pnas.92.25.11894","volume":"92","author":"K Chu","year":"1995","unstructured":"Chu K, Niu X, Williams LT. A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc Natl Acad Sci U S A. 1995;92:11894\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2677_CR54","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1038\/onc.2014.264","volume":"34","author":"Q Cai","year":"2015","unstructured":"Cai Q, Yan L, Xu Y. Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells. Oncogene. 2015;34:3315\u201324.","journal-title":"Oncogene"},{"key":"2677_CR55","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.4161\/cc.8.16.9280","volume":"8","author":"CW Menges","year":"2009","unstructured":"Menges CW, Altomare DA, Testa JR. FAS-associated factor 1 (FAF1): diverse functions and implications for oncogenesis. Cell Cycle. 2009;8:2528\u201334.","journal-title":"Cell Cycle"},{"key":"2677_CR56","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.3389\/fimmu.2019.02537","volume":"10","author":"R Gr\u00f6bner","year":"2019","unstructured":"Gr\u00f6bner R, Kapferer-Seebacher I, Amberger A, Redolfi R, Dalonneau F, Bj\u00f6rck E, Milnes D, Bally I, Rossi V, Thielens N, et al. C1R Mutations Trigger Constitutive Complement 1 Activation in Periodontal Ehlers-Danlos Syndrome. Front Immunol. 2019;10:2537.","journal-title":"Front Immunol"},{"key":"2677_CR57","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nri.2017.97","volume":"18","author":"ES Reis","year":"2018","unstructured":"Reis ES, Mastellos DC, Ricklin D, Mantovani A, Lambris JD. Complement in cancer: untangling an intricate relationship. Nat Rev Immunol. 2018;18:5\u201318.","journal-title":"Nat Rev Immunol"},{"key":"2677_CR58","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1172\/JCI90962","volume":"127","author":"V Afshar-Kharghan","year":"2017","unstructured":"Afshar-Kharghan V. The role of the complement system in cancer. J Clin Invest. 2017;127:780\u20139.","journal-title":"J Clin Invest"},{"key":"2677_CR59","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","volume":"19","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, Daugan MV, Petitprez F, Saut\u00e8s-Fridman C, Fridman WH. Context-dependent roles of complement in cancer. Nat Rev Cancer. 2019;19:698\u2013715.","journal-title":"Nat Rev Cancer"},{"key":"2677_CR60","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1158\/2326-6066.CIR-18-0891","volume":"7","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, Daugan MV, No\u00e9 R, Petitprez F, Vano YA, Sanchez-Salas R, Becht E, Meilleroux J, Clec\u2019h BL, Giraldo NA, et al. Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth. Cancer Immunol Res. 2019;7:1091\u2013105.","journal-title":"Cancer Immunol Res"},{"key":"2677_CR61","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/03936155231161366","volume":"38","author":"C Yang","year":"2023","unstructured":"Yang C, Yang F, Chen X, Li Y, Hu X, Guo J, Yao J. Overexpression of complement C5a indicates poor survival and therapeutic response in metastatic renal cell carcinoma. Int J Biol Markers. 2023;38:124\u201332.","journal-title":"Int J Biol Markers"},{"key":"2677_CR62","doi-asserted-by":"crossref","unstructured":"Netti GS, Franzin R, Stasi A, Spadaccino F, Dello Strologo A, Infante B, Gesualdo L, Castellano G, Ranieri E, Stallone G. Role of Complement in Regulating Inflammation Processes in Renal and Prostate Cancers. Cells. 2021;10:2426.","DOI":"10.3390\/cells10092426"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02677-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02677-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02677-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:02:47Z","timestamp":1782093767000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02677-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2677"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02677-8","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"28 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was obtained from the Ethics Committee of Second Hospital of Tianjin Medical University (Approval No. KY2025K015). Animal experiments were approved by the Animal Ethical and Welfare Committee of Tianjin Medical University Cancer Institute and Hospital (Approval No. 2023089). Informed consent was obtained from all participants, and the study adhered to the principles of the 1975 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}